ZA924242B - Re-formulated diamox sustets - Google Patents

Re-formulated diamox sustets

Info

Publication number
ZA924242B
ZA924242B ZA924242A ZA924242A ZA924242B ZA 924242 B ZA924242 B ZA 924242B ZA 924242 A ZA924242 A ZA 924242A ZA 924242 A ZA924242 A ZA 924242A ZA 924242 B ZA924242 B ZA 924242B
Authority
ZA
South Africa
Prior art keywords
sustets
diamox
formulated
drug
release
Prior art date
Application number
ZA924242A
Other languages
English (en)
Inventor
Nicholas Ian Payne
Ian Payne Nicholas
David Parker
Parker David
Angela Catherine Potts
Catherine Potts Angela
Laurence Charles Staines
Charles Staines Laurence
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA924242B publication Critical patent/ZA924242B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA924242A 1991-06-11 1992-06-10 Re-formulated diamox sustets ZA924242B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9112495A GB2256587A (en) 1991-06-11 1991-06-11 Acetazolamide in sustained release form

Publications (1)

Publication Number Publication Date
ZA924242B true ZA924242B (en) 1993-03-31

Family

ID=10696429

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA924242A ZA924242B (en) 1991-06-11 1992-06-10 Re-formulated diamox sustets

Country Status (11)

Country Link
EP (1) EP0540813B1 (fi)
AT (1) ATE135568T1 (fi)
CA (1) CA2070877C (fi)
DE (1) DE69209228T2 (fi)
DK (1) DK0540813T3 (fi)
ES (1) ES2086576T3 (fi)
FI (1) FI101855B1 (fi)
GB (1) GB2256587A (fi)
GR (1) GR3019751T3 (fi)
NO (1) NO922282L (fi)
ZA (1) ZA924242B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
AR036797A1 (es) 2001-10-15 2004-10-06 Ferring Bv Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
EP1615619A2 (en) 2003-04-23 2006-01-18 Ferring B.V. Sachet for a pharmaceutical composition
EP1547601A1 (en) 2003-12-23 2005-06-29 Ferring B.V. Coating method
RU2009137946A (ru) 2007-03-15 2011-04-20 Шеринг Корпорейшн (US) Производные пиридазинона для применения в качестве ингибиторов глюкансинтазы
CN102949377B (zh) * 2012-11-28 2015-05-27 河南中帅医药科技股份有限公司 乙酰唑胺缓释胶囊及其制备方法
CN106822015A (zh) * 2017-03-27 2017-06-13 华益药业科技(安徽)有限公司 乙酰唑胺缓释片及其制备方法
CN113855648B (zh) * 2021-12-03 2022-02-25 北京联嘉医药科技开发有限公司 一种乙酰唑胺缓释胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3671633A (en) * 1971-05-10 1972-06-20 American Cyanamid Co Process for tabletting acetazolamide
US4305927A (en) * 1979-02-05 1981-12-15 Alza Corporation Method for the management of intraocular pressure
GB2135879B (en) * 1983-03-07 1986-05-21 Ciba Geigy Ag Pharmaceutical preparations with uniform elution properties
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
EP0418597A3 (en) * 1989-09-21 1991-11-27 American Cyanamid Company Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form

Also Published As

Publication number Publication date
FI922698A (fi) 1992-12-12
CA2070877A1 (en) 1992-12-12
GB2256587A (en) 1992-12-16
CA2070877C (en) 2003-02-11
NO922282D0 (no) 1992-06-10
GB9112495D0 (en) 1991-07-31
NO922282L (no) 1992-12-14
EP0540813B1 (en) 1996-03-20
FI922698A0 (fi) 1992-06-10
DE69209228D1 (de) 1996-04-25
GR3019751T3 (en) 1996-07-31
ES2086576T3 (es) 1996-07-01
FI101855B (fi) 1998-09-15
DE69209228T2 (de) 1996-11-21
ATE135568T1 (de) 1996-04-15
DK0540813T3 (da) 1996-07-22
EP0540813A1 (en) 1993-05-12
FI101855B1 (fi) 1998-09-15

Similar Documents

Publication Publication Date Title
TW337488B (en) A carbohydrate glass matrix for the sustained release of a therapeutic agent
ES2191034T3 (es) Formulaciones de liberacion controlada para la liberacion de metoprolol durante 24 horas.
DE69431247D1 (de) Oxybutyninformulierungen mit gesteuerter freisetzung
CA2079325A1 (en) Nutritional supplement containing vitamin e
EP1468679A3 (en) Controlled release formulation containing tramadol
EP1504758A3 (en) Controlled-release formulations coated with aqueous dispersions of ethylcellulose
HU9502994D0 (en) Active substance-containing plaster
EP0595133A3 (de) Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
EP0823993A3 (en) PH-sensitive microcapsules
AU1560692A (en) Capsule
EP0160501A3 (en) Sustained release intranasal formulation and method of use thereof
EP0228833A3 (en) Immunostimulant agents
ZA924242B (en) Re-formulated diamox sustets
ES8505802A1 (es) Procedimiento para la obtencion de pesticidas a base de microemulsiones en agua.
EP0246331A4 (en) INSECTICIDE COMPOSITION.
Wayland Effects of the carbamate insecticide, carbofuran, on macroinvertebrates in prairie ponds
IT1295210B1 (it) Concime od integratore per le piante, a base di propoli e procedimento per la fabbricazione e per l'uso di tale concime.
AU5546490A (en) Enantiomer-free 1,2-aminoalcohols acetalically protected on the oxygen, their production and use